Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
On the 12th of November, at 3 PM, Releaf is teaming up with MS-UK (the UK's leading multiple sclerosis charity) to bring patients, caregivers, and healthcare professionals a free webinar discussing the increasingly significant role of medicinal cannabis in treating symptoms associated with multiple sclerosis.
We will be touching on the latest research and developments in medical cannabis for multiple sclerosis, as well as providing insight into the potential benefits and risks of this natural treatment option. This webinar is a valuable opportunity for those living with MS (as well as carers and loved ones) to learn more about medical cannabis, ask any lingering questions that they may have, and gain a better understanding of how medicinal cannabis can help people with MS.
MS is a neurological condition in which the immune system misfires and attacks the central nervous system. This can result in inflammation and damage to the brain, spinal cord, and optic nerve. Symptoms like muscle stiffness, spasms, and pain are common, as are cognitive and emotional changes.
With around 150,000 people diagnosed with multiple sclerosis in the UK, and no cure in sight, the main focus for MS patients is on managing symptoms and improving quality of life. This is where medicinal cannabis comes in.
While there are a range of conventional treatment options available, for some they simply do not work, and the side effects can be difficult to manage.
And while medical cannabis is not a cure for MS, and should never be viewed as such, it has been shown, through rigorous research, to help ease many of the symptoms of multiple sclerosis. This primarily includes muscle stiffness and spasms, but also pain, inflammation, fatigue, sleep issues, and there’s also evidence to suggest medical cannabis can decrease anxiety, while boosting day-to-day mood. In addition to this, medicinal cannabis is also generally well-tolerated and has minimal side effects associated with treatment.
MS-UK is a UK-based independent charity focused on providing information and support to those living with multiple sclerosis. With zero financial support from the UK government or pharmaceutical companies, this charity is driven by the wants and needs of those living with MS and is free from any potential bias that can come with receiving funding from sources that may have certain agendas.
Their core mission is to empower people affected by MS with the information and support they need to make educated decisions about their health and treatment options.
MS-UK produces a wealth of resources, including a bi-monthly magazine (New Pathways) that explores the latest research, treatments, and lifestyle advice for managing MS symptoms, as well as an eLearning course that offers a comprehensive overview of the causes, types, diagnoses, symptoms, and treatments of MS.
They also offer free personalised support to patients, loved ones, carers, and health care professionals through their phone line, email, live web chat, WhatsApp, and video conferencing. The MS-UK helpline is available for contact Monday to Friday between 10 AM and 4 PM.
As the UK's fastest-growing medical cannabis clinic, we understand that the needs of our ever-increasing patient base go beyond just providing medical cannabis consultations and cannabis-based medicines. We want patients to have access to the latest information, research, and support to help them manage their conditions holistically.
Partnering with MS-UK allows us to reach a wider audience and share our knowledge and expertise on medicinal cannabis for MS. The webinar will be hosted by Dr Michal Modestowicz (Releaf's expert Neurologist) and Charlene Rowe (Releaf's Head of Patient Engagement and Support), who will share their extensive experience in helping MS patients with medical cannabis treatment.
We spoke to Dr Modestowicz about the upcoming webinar and why he's excited to be part of it. Dr Modestowicz said:
“I’m really looking forward to this webinar. Opportunities like these allow us to connect with the MS community and discuss how medicinal cannabis may help in managing the many symptoms of multiple sclerosis."
"We’ll cover the latest insights on its potential benefits and address some common questions and concerns. It’s a great chance for anyone interested in learning more to hear directly from people professionally involved in the field and for us to table any questions that patients may have."
If you or a loved one have been diagnosed with MS and are looking to learn more about all the available treatment options, we highly recommend checking out the resources provided by MS-UK and heading over to their website to find out more about this webinar.
Their dedication to offering bias-free, researched-backed information and support is truly commendable, and we are proud to be partnering with them to bring more awareness to the potential benefits of medicinal cannabis for MS patients.
To learn more, head to our education hub and blog, as well as our medical cannabis glossary and full FAQ section.
And don't forget to register and sign up for the free MS UK/Releaf medical cannabis for MS webinar on 12 November at 3 PM to hear from our experts and get your questions answered. We hope to see you there!
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sam North, a seasoned writer with over five years' experience and expertise in medicinal cannabis, brings clarity to complex concepts, focusing on education and informed use.
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
This week is Multiple Sclerosis (MS) Awareness Week, where we shine a spotlight on this chronic disease that affects more than 130,000 people in the UK (and millions worldwide), and see how the change to UK medical cannabis laws is opening up new treatment options.
Sam North
While cannabis is still classed as a Class B controlled drug under the Misuse of Drugs Act 1971, in November 2018, the laws surrounding medicinal cannabis shifted in the UK. After decades of lobbying by patient advocacy organisations, doctors, and scientists, medicinal cannabis was finally made available on prescription for patients suffering from certain conditions, with multiple sclerosis (MS) making it on the list.
Sam North
The medicinal cannabis landscape is shifting in the United Kingdom, and with this shift comes increased options for people suffering from multiple sclerosis. MS, unfortunately, currently has no cure. And as the symptoms are so wide-ranging, the treatment options are focused on managing the different symptoms and attempting to slow down or stop further possible damage. There truly is no one-size-fits-all approach when it comes to treating MS. Research into both THC and CBD has shown promise when it comes to the reduction of symptoms related to MS.
Sam North
Cannabis-based medicines can be prescribed to patients in the UK for the treatment of a wide range of conditions. Among these are several neurological conditions, including multiple sclerosis, epilepsy, Parkinson’s disease and ADHD. In this article, we take a look at the causes and characteristics of these conditions and assess the evidence for the potential efficacy of medical cannabis.
Emily Ledger
